MedTrace Logo

Optimizing Left Ventricular Lead To Improve Cardiac Output

NCT01399801 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2022-08-30

No results posted yet for this study

Summary

The purpose of this study is to determine if optimal lead placement, guided by the largest improvement in aortic flow measured by Doppler will:

1. Improve the way the heart's left ventricle functions
2. Decrease the number of hospital admissions for heart failure related symptoms
3. Reduces uncoordinated heart contractions
4. Improve quality of life as measured by the Minnesota Living with Heart Failure Questionaire and NYHA Class assessed after six months

Conditions

  • Ischemic Congestive Cardiomyopathy
  • Dilated Cardiomyopathy
  • Congestive Heart Failure

Interventions

PROCEDURE

Doppler flow measurement

use of doppler wire to measure change in flow that corresponds to changes in stroke volume to guide LV lead placement

PROCEDURE

standard implantation of the LV lead

Standard implantation of the LV lead with measurements of flow

Sponsors & Collaborators

  • Main Line Health

    collaborator OTHER

  • Ann Marie Chikowski

    lead OTHER

Principal Investigators

  • Dusan Kocovic, MD · Lankenau Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2014-09-25
Completion
2014-09-25

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01399801 on ClinicalTrials.gov